Summit Therapeutics

SMMT

Valor de mercado US$ 12,1 bi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Lansdowne Partners (UK) London, United Kingdom	US$ 10,6 mi	–	–	–
2	2 Point72 Asset Management Stamford, Connecticut	US$ 9,13 mi	–	–	–
3	3 Axa Paris, France	US$ 3,27 mi	-US$ 82,3 mil	-7.309	-2%
4	4 First Eagle Investment Management New York	US$ 1,92 mi	–	–	–
5	5 Sphera Funds Management Tel Aviv, Israel	US$ 1,56 mi	-US$ 61,2 mil	-5.432	-4%
6	6 Granite Point Capital Management Boston, Massachusetts	US$ 1,33 mi	–	–	–
7	KCM 7 Knoll Capital Management Miami, Florida	US$ 1,1 mi	–	–	–
8	8 Millennium Management New York	US$ 864 mil	-US$ 59,3 mil	-5.270	-6%
9	9 Renaissance Technologies New York	US$ 439 mil	+US$ 207 mil	+18.398	+92%
10	10 Acadian Asset Management Boston, Massachusetts	US$ 145 mil	+US$ 11	+1	+0%
11	11 Deutsche Bank Frankfurt Am Main Ge, Germany	US$ 81 mil	+US$ 22,1 mil	+1.964	+38%
12	12 Royal Bank of Canada Toronto, Ontario, Canada	US$ 28 mil	+US$ 28,1 mil	+2.500	Nova
13	13 State of Tennessee, Department of Treasury Nashville, Tennessee	US$ 17 mil	-US$ 8,25 mil	-733	-33%
14	14 Tower Research Capital (TRC) New York	US$ 3 mil	+US$ 3,38 mil	+300	Nova
15	15 Morgan Stanley New York	–	-US$ 89 mil	-6.721	Encerrada
16	16 Wells Fargo San Francisco, California	–	-US$ 16 mil	-1.200	Encerrada
17	17 UBS Group Zurich, Switzerland	–	-US$ 9 mil	-702	Encerrada